BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20623938)

  • 21. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 22. A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.
    Fu X; Wang Y; Wang C; Wu H; Li J; Li M; Ma Q; Yang W
    Clin Rehabil; 2018 Jun; 32(6):713-721. PubMed ID: 29582713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial].
    Lipták J
    Ideggyogy Sz; 2013 Jul; 66(7-8):283-4. PubMed ID: 23971362
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacological treatment of spasticity in multiple sclerosis].
    Heinzlef O; Monteil-Roch I
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S62-8. PubMed ID: 22721367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
    Weynants L; Van Laere M
    Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug therapy: spasticity (second of two parts).
    Young RR; Delwaide PJ
    N Engl J Med; 1981 Jan; 304(2):96-9. PubMed ID: 7003385
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrathecal baclofen for motor disorders.
    Penn RD; Gianino JM; York MM
    Mov Disord; 1995 Sep; 10(5):675-7. PubMed ID: 8552124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral palsy therapy].
    Papazian O; Alfonso I
    Rev Neurol; 1997 May; 25(141):728-39. PubMed ID: 9206600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intrathecal therapy for bladder hyperreflexia].
    Denys P; Even-Schneider A; Rémy-Néris O; Ben Smaïl D; Chartier-Kastler E; Bussel B
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):395-8. PubMed ID: 12746716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 32. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [To make easier everyday life of stroke patients. Muscle relaxants diminish spasms].
    MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666538
    [No Abstract]   [Full Text] [Related]  

  • 34. Spasticity: revisiting the role and the individual value of several pharmacological treatments.
    Lapeyre E; Kuks JB; Meijler WJ
    NeuroRehabilitation; 2010; 27(2):193-200. PubMed ID: 20871149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coma induced by an overdose of intrathecal baclofen].
    Alonso-Navarro H; Adeva-Bartolomé MT; Martín-Prieto M; Ruiz-Ezquerro JJ; Jiménez-Jiménez FJ
    Rev Neurol; 2006 Jul 1-15; 43(1):63-4. PubMed ID: 16807874
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
    Taricco M; Pagliacci MC; Telaro E; Adone R
    Eura Medicophys; 2006 Mar; 42(1):5-15. PubMed ID: 16565680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spastic syndrome and main directions of its treatment].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):4-9. PubMed ID: 14763249
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of spasticity in adults.
    Nair KP; Marsden J
    BMJ; 2014 Aug; 349():g4737. PubMed ID: 25096594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.